Perflenapent emulsion (EchoGen®): A new long-acting phase-shift agent for contrast echocardiography

Clinical Cardiology

Volumn 20, Issue 10 SUPPL., 1997, Pages

  Grayburn, Paul ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Contrast echocardiography; EchoGen ; Fluorocarbon; Perflenapent emulsion; Phase shift colloid

Indexed keywords

PERFLUOROPENTANE;

BACKACHE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; HEADACHE; HEART PERFUSION; HUMAN; PAIN; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; REVIEW;

EID: 0030708516     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960201305     Document Type: Review

References (12)

1. ® emulsion: A new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996; 51(suppl I):11-14
2. ®. In Ultrasound Contrast Agents (Ed. Goldberg BB), p. 101-120. London, Martin Dunitz, 1997
3. ®) in patients with suboptimal echoes. Presented at the Annual Meeting of the American Heart Association, November 10-13, 1996, New Orleans, La.
4. ® emulsion: Ultrasound contrast media. Drugs of the Future 1997;22(4):378-385
5. Melany ML, Grant EG: Clinical experience with sonographic contrast agents. Semin Ultrasound CT MR 1997;18(1):3-12
6. Crouse LJ, Cheirif J, Hanly DE, Kisslo JA, Labovitz AJ, Raichlen JS, Schutz RW, Shah PM, Smith MD: Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex Multicenter Trial. J Am Coll Cardiol 1993;22: 1494-1500
7. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA: Intravenous dodecafluoropentene improves determination of left ventricular functionduring echocardiography (abstr). J Am Coll Card 1997;27:520A
8. Quay SC, Eisenfeld A: Safety assessment of the use of perflenapent emulsion for the contrast enhancement of echocardiography and diagnostic radiology ultrasound studies. Clin Cardiol October 1997;20 (suppl I):
9. ® product information. St. Louis, Mo.: Mallinckrodt Medical, 1995
10. Grayburn PA, Erikson JM, Escobar J, Womack L, Velasco CE: Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluorepentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 1995;26:1340-1347
11. Feigenbaum H: Echocardiography. 5th ed, p. 68-133. Philadelphia, Pa: Lea & Febiger, 1994
12. Yvorchuk KJ, Sochowski RA, Chan KL: Sonicated albumin in exercise echocardiography: Technique and feasibility to enhance endocardial visualization. J Am Soc Echocardiogr 1996;9(4): 462-469